← Back to patent-cliff list
CAS 1196964-06-3
dimethyl (2S,4S)-2-((tert-butoxycarbonyl)amino)-4-(3-(fluoro-18F)propyl)pentanedioate
Codes: BAY-94-9392-005
Application context (from source-drug indications)
Colorectal cancerBAY-94-9392Lung cancerBAY-94-9392孤立性肺结节BAY-94-9392Smoking cessationBAY-94-9392CholangiocarcinomaBAY-94-9392Liver cancerBAY-94-9392
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| BAY-94-9392 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
BAY-94-9392→dimethyl (tert-butoxycarbonyl)-L-glutamate→dimethyl (2S,4S)-2-allyl-4-((tert-butoxycarbonyl)amino)pentanedioate→dimethyl (2S,4S)-2-((tert-butoxycarbonyl)amino)-4-(3-hydroxypropyl)pentanedioate→dimethyl (2S,4S)-2-((tert-butoxycarbonyl)amino)-4-(3-fluoropropyl)pentanedioate→dimethyl (2S,4S)-2-((tert-butoxycarbonyl)amino)-4-(3-(fluoro-18F)propyl)pentanedioate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.